Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Applying polypharmacology approach for drug repurposing for SARS-CoV2
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
Journal of Chemical Sciences (2022) Vol. 134, Iss. 2
Open Access | Times Cited: 14

Showing 14 citing articles:

Multilayered screening for multi-targeted anti-Alzheimer’s and anti-Parkinson’s agents through structure-based pharmacophore modelling, MCDM, docking, molecular dynamics and DFT: a case study of HDAC4 inhibitors
Nikita Chhabra, Balaji Wamanrao Matore, Nisha Lakra, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Polypharmacology guided drug repositioning approach for SARS-CoV2
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289890-e0289890
Open Access | Times Cited: 7
Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer
Kikrusenuo Kiewhuo, Lipsa Priyadarsinee, Himakshi Sarma, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 12734-12752
Open Access | Times Cited: 6
Molecular Property Diagnostic Suite for COVID-19 (MPDSCOVID-19): an open-source disease-specific drug discovery portal
Lipsa Priyadarsinee, Esther Jamir, Selvaraman Nagamani, et al.
Gigabyte (2024) Vol. 2024, pp. 1-17
Open Access | Times Cited: 1
Glycoprotein attachment with host cell surface receptor ephrin B2 and B3 in mediating entry of nipah and hendra virus: a computational investigation
Lipsa Priyadarsinee, Himakshi Sarma, G. Narahari Sastry
Journal of Chemical Sciences (2022) Vol. 134, Iss. 4
Open Access | Times Cited: 8
Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
Mithun Rudrapal, Keshav Raj Paudel, Rudra Pangeni
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2
Anshika Gupta, Shweta Singh Chauhan, Anamika Singh Gaur, et al.
Structural Chemistry (2022) Vol. 33, Iss. 6, pp. 2179-2193
Open Access | Times Cited: 5
Mapping of Zika virus-host protein-protein interactions using yeast two-hybrid system and identification of re-purposed drug targets
Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, Vinod Balasubramaniam
Research Square (Research Square) (2024)
Open Access
Biomarker driven drug repurposing for Fuchs’ Endothelial Corneal Dystrophy (FECD): A Computational study
Sarangthem Dinamani Singh, Gayatri Gogoi, Selvaraman Nagamani, et al.
Research Square (Research Square) (2024)
Open Access
Exploring bacterial metabolites in microbe-human host dialogue and their therapeutic potential in Alzheimer’s diseases
Sarangthem Dinamani Singh, Pankaj Bharali, Selvaraman Nagamani
Molecular Diversity (2024)
Closed Access
Targeting RdRp of SARS-CoV-2 with De Novo Molecule Generation
Amal Vijay, Venkata Sai Sreyas Adury, Arnab Mukherjee
ACS Applied Bio Materials (2023) Vol. 7, Iss. 2, pp. 609-616
Open Access | Times Cited: 1
Molecular Property Diagnostic Suite for COVID-19 (MPDSCOVID-19): An open access disease specific drug discovery portal
Lipsa Priyadarsinee, Esther Jamir, Selvaraman Nagamani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
A structure-based drug repurposing approach by considering the twenty four SARS-CoV2 Targets: A consensus scoring approach
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2
Jesus Campagna, Barbara Jagodzinska, Pablo Jorge Masías Alvarez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top